Inhibiting Cycloxygenase and Ornithine Decarboxylase by Diclofenac and Alpha-Difluoromethylornithine Blocks Cutaneous SCCs by Targeting Akt-ERK Axis

• Aadithya Arumugam,

  Affiliation Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Zhiping Weng,

  Affiliation Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Sarang S. Talwelkar,

  Affiliation Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Sandeep C. Chaudhary,

  Affiliation Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Levy Kopelovich,

  Affiliation Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Craig A. Elmets,

  Affiliations Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America, Skin Diseases Research Center, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Farrukh Afaq,

  Affiliation Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Mohammad Athar

  * E-mail: mathar@uab.edu

  Affiliations Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America, Skin Diseases Research Center, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯